A detailed history of Viawealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Viawealth, LLC holds 7,836 shares of NVO stock, worth $887,427. This represents 0.69% of its overall portfolio holdings.

Number of Shares
7,836
Previous 7,836 -0.0%
Holding current value
$887,427
Previous $1.01 Billion 11.17%
% of portfolio
0.69%
Previous 0.63%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $687,844 - $826,306
7,836 New
7,836 $811 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Viawealth, LLC Portfolio

Follow Viawealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viawealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Viawealth, LLC with notifications on news.